Start here if you're new
what it is
IPG sells industrial lasers that help manufacturers cut, weld, clean, and build things with light.
how it gets paid
Last year Ipg Photonics made $1.0B in revenue.
why it's growing
Revenue grew 2.7% last year. Sales in europe rose 7%, driven by a spike in demand for additive manufacturing applications.
what just happened
Latest results showed EPS of $0.46, beating the $0.24 estimate by 91.67%.
At a glance
B++ balance sheet — above average — nothing keeping you up at night
10/100 earnings predictability — expect surprises
85.8x trailing p/e — you're paying up for this one
7.5% return on capital — nothing to write home about
xvary composite: 56/100 — below average
What they do
IPG sells industrial lasers that help manufacturers cut, weld, clean, and build things with light.
IPG builds the laser source, the amplifiers, and key components itself, which gives you tighter control over cost and performance. That vertical integration (making more of your own parts instead of buying them) matters because laser buyers care about uptime, and IPG supports them with 100+ field service engineers globally. The company also still produced $1.0B of annual revenue and has a B++ balance sheet, which gives it room to survive a weak cycle better than smaller rivals.
How they make money
$1.0B
annual revenue · their business grew +2.7% last year
total revenue
$1.0B
+2.7%
The products that matter
industrial and specialty laser systems
Fiber lasers and related products
$1.0B revenue · effectively the whole business
this is the full revenue base in the snapshot data. If cutting, welding, cleaning, medical, or additive manufacturing demand weakens, there is no second engine here to bail out the quarter.
100% of revenue
Key numbers
85.8x
trailing p/e
You are paying 85.8 times trailing earnings for a company with a 1.3% operating margin, which means the market already expects a sharp profit recovery.
1.3%
operating margin
Operating margin means profit after running the business. At 1.3%, IPG is barely keeping each sales dollar.
$1.0B
annual revenue
The company is back to growth, but barely. Revenue rose 2.7% vs. prior year, so the top line is improving faster than the old trend but not booming.
41.5%
eps growth
Projected earnings growth is 41.5%, which tells you the bull case is really about margins recovering, not just sales creeping higher.
Financial health
B++
strength
- balance sheet grade B++ — above average financial health
- risk rank 3 — safer than 50% of stocks
- price stability 30 / 100
- net profit margin 13.0% — keeps 13 cents of every dollar in revenue
- return on equity 8% — $0.08 profit for every $1 investors have put in
B++ — functional but not a standout on the balance sheet.
Total return vs. market
You invested $10,000 in IPGP 3 years ago → it's now worth $10,090.
The index would have given you $14,540.
source: institutional data · total return
What just happened
beat estimates
Latest results showed EPS of $0.46, beating the $0.24 estimate by 91.67%.
Revenue rose to about $274.5M in Q4 2025, up 17.2% vs. prior year, helped by stronger materials processing and medical demand. Gross margin came in at 38.7%, which matters because margin repair is the whole story here.
$274.5M
revenue
$0.46
eps
38.7%
gross margin
the number that mattered
The key number was the 91.67% EPS beat, because it showed profits recovered faster than analysts expected even after a weak 2024.
-
ipg photonics has posted good top-line results.
-
in 2025, sales in north america increased 23%, thanks to higher revenue in cutting, cleaning, medical, and advanced applications.
-
sales in europe rose 7%, driven by a spike in demand for additive manufacturing applications.
-
revenues in asia surged 19% due to elevated welding sales in china.
-
the overall top line benefited from the 2024 acquisition of cleanlaser.
source: company earnings report, 2026
Get this snapshot in your inbox
This page, delivered free — plus weekly updates when the numbers change. plain english, no spam.
weekly updates
earnings alerts
plain english
no spam
What could go wrong
IPG sells one core technology stack into several end markets. That sounds diversified until orders soften at the same time. The main risk here is not balance sheet stress. It is demand volatility hitting an already expensive setup.
med
10/100 predictability is the story, not a footnote
A 10/100 earnings predictability score means the business has been hard to forecast. When quarterly visibility is this thin, sentiment can flip on one report.
That uncertainty sits on top of the full $1.0B revenue base. There is no second reporting segment here to absorb a weak industrial patch.
med
the multiple already assumes the recovery gets better
The stock trades at 85.8x trailing earnings and about 60.9x the $2.00 FY2026 EPS estimate. That's premium pricing for a company that grew revenue 2.7% last year.
If growth stalls or margins slip, both earnings and the multiple can compress at the same time. That's how a stock goes from merely expensive to suddenly painful.
med
vertical integration still has to earn its premium
Building core components in-house gives IPG control over product design and production. The economic payoff still looks thin, with 6% return on equity and 5.5% return on capital.
If that control does not convert into better returns, you are left owning a more complicated manufacturer without premium shareholder economics.
when a $1.0B business with 10/100 predictability trades at 85.8x trailing earnings, a modest demand miss can pressure both the income statement and the multiple.
source: institutional data · regulatory filings · risk analysis
Pay attention to
earnings
next quarter against the $235M–$265M range
Management gave a wide revenue band. Where the actual number lands inside it will tell you whether demand is stabilizing or just bouncing around.
metric
the $2.00 FY2026 EPS estimate
That estimate sits above the $1.42 posted in FY2025. If analysts start cutting it, the valuation argument gets thinner fast.
trend
regional demand staying broad
North America was up 23%, Europe rose 7%, and Asia jumped 19%. You want the strength spread across regions, not concentrated in one temporary pocket.
risk
whether Clean-Laser becomes more than a revenue patch
The acquisition helped the top line. The real test is whether it supports demand and earnings, not just reported comparisons.
Analyst rankings
short-term outlook
average
momentum score 3. In human-speak, analysts do not see a strong near-term edge either way.
risk profile
average
stability score 3 means middle-of-the-road balance sheet risk, not middle-of-the-road earnings certainty. Those are different things.
chart momentum
average
technical score 3 says the chart is behaving like the market, not sending a strong standalone signal.
earnings predictability
10 / 100
This is the outlier. Forecasting profits here has been difficult, which helps explain why the stock can feel calm until it suddenly doesn't.
source: institutional data
Institutional activity
94 buyers vs. 98 sellers in 4q2025. total institutional holdings: 29.4M shares.
source: institutional data
Price targets
3-5 year target range
$42
$165
$122
current price
$104
target midpoint · 15% from current · 3-5yr high: $160 (+30% · 7% ann'l return)
Want the deeper analysis?
The full deep dive: dcf model, scenario analysis, competitive moat breakdown, and quarterly tracking — everything on this page, taken further.
see plans from $5/moThe deep dive